Trevi Therapeutics (TRVI)
Trevi Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
16.0M
Short interest
settlement 2026-10-15
4.5
Days to cover
-3.9 days vs prior
67.3%
Short share of volume
2026-11-02
6,351
Fails to deliver
settlement 2026-09-22
Thu 12 Nov
Next earnings
estimated date
-$596K
Insider flow, 90 days
0 buys, 4 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in TRVI is 16,007,187 shares, up 3,936,562 shares over the last month. Over the last 48 readings it ranged from 1,413,263 shares (29 November 2024) to 16,813,915 shares (27 February 2026). The latest reading sits at the top of that range. At the reported average volume of 3.6M shares a day that is 4.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/trvi" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 16,007,187 | +9.3% | 3,582,888 | 4.47 |
| 2026-09-30 | 14,639,150 | +21.3% | 1,756,639 | 8.33 |
| 2026-09-15 | 12,070,625 | +0.5% | 1,373,723 | 8.79 |
| 2026-08-31 | 12,012,371 | -5.1% | 1,494,034 | 8.04 |
| 2026-08-14 | 12,657,630 | -3.7% | 1,617,552 | 7.83 |
| 2026-07-31 | 13,147,012 | +3.9% | 2,434,305 | 5.40 |
| 2026-07-15 | 12,653,483 | -8.8% | 2,659,448 | 4.76 |
| 2026-06-30 | 13,870,118 | -3.4% | 3,465,819 | 4.00 |
| 2026-06-15 | 14,351,654 | +5.7% | 971,606 | 14.77 |
| 2026-05-29 | 13,574,699 | +2.1% | 1,094,911 | 12.40 |
| 2026-05-15 | 13,289,352 | -13.1% | 1,525,091 | 8.71 |
| 2026-04-30 | 15,291,551 | -5.3% | 2,274,244 | 6.72 |
| 2026-04-15 | 16,139,168 | +5.5% | 1,200,702 | 13.44 |
| 2026-03-31 | 15,295,203 | -7.0% | 1,359,486 | 11.25 |
| 2026-03-13 | 16,442,993 | -2.2% | 1,358,462 | 12.10 |
| 2026-02-27 | 16,813,915 | +5.0% | 1,114,052 | 15.09 |
| 2026-02-13 | 16,010,995 | +3.3% | 1,334,825 | 11.99 |
| 2026-01-30 | 15,504,499 | -0.3% | 1,583,339 | 9.79 |
| 2026-01-15 | 15,556,094 | +10.3% | 1,406,785 | 11.06 |
| 2025-12-31 | 14,105,563 | +3.3% | 1,476,215 | 9.56 |
| 2025-12-15 | 13,651,656 | +1.9% | 2,617,433 | 5.22 |
| 2025-11-28 | 13,403,743 | -9.3% | 2,146,416 | 6.24 |
| 2025-11-14 | 14,784,433 | -5.4% | 1,510,980 | 9.78 |
| 2025-10-31 | 15,623,820 | +7.1% | 1,462,214 | 10.69 |
| 2025-10-15 | 14,589,302 | -1.6% | 1,690,473 | 8.63 |
| 2025-09-30 | 14,825,735 | +22.6% | 2,223,238 | 6.67 |
| 2025-09-15 | 12,090,295 | +3.5% | 3,588,951 | 3.37 |
| 2025-08-29 | 11,684,736 | +15.6% | 2,433,501 | 4.80 |
| 2025-08-15 | 10,111,945 | -0.5% | 1,341,642 | 7.54 |
| 2025-07-31 | 10,160,448 | +2.1% | 2,050,308 | 4.96 |
| 2025-07-15 | 9,951,259 | +8.3% | 1,650,518 | 6.03 |
| 2025-06-30 | 9,184,965 | +20.4% | 1,518,669 | 6.05 |
| 2025-06-13 | 7,627,036 | +8.6% | 3,647,376 | 2.09 |
| 2025-05-30 | 7,023,898 | +2.3% | 1,052,328 | 6.67 |
| 2025-05-15 | 6,869,392 | -1.2% | 1,069,506 | 6.42 |
| 2025-04-30 | 6,953,865 | +17.6% | 1,314,529 | 5.29 |
| 2025-04-15 | 5,911,171 | +7.4% | 1,776,435 | 3.33 |
| 2025-03-31 | 5,503,093 | +17.7% | 1,704,247 | 3.23 |
| 2025-03-14 | 4,676,973 | +23.4% | 7,087,419 | 1.00 |
| 2025-02-28 | 3,791,658 | -12.4% | 1,362,521 | 2.78 |
| 2025-02-14 | 4,328,742 | -5.8% | 503,733 | 8.59 |
| 2025-01-31 | 4,592,706 | +11.1% | 398,868 | 11.51 |
| 2025-01-15 | 4,133,956 | +6.9% | 622,071 | 6.65 |
| 2024-12-31 | 3,866,770 | -16.9% | 1,132,660 | 3.41 |
| 2024-12-13 | 4,656,062 | +229.4% | 7,210,507 | 1.00 |
| 2024-11-29 | 1,413,263 | -19.4% | 485,785 | 2.91 |
| 2024-11-15 | 1,752,876 | +2.1% | 585,102 | 3.00 |
| 2024-10-31 | 1,716,395 | +12.7% | 638,819 | 2.69 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of TRVI volume is 67.3%, down 6.1 points over the last five sessions. Over the last 30 readings it ranged from 31.8% (16 October 2026) to 77.4% (22 September 2026). The latest reading is 6.0 points above the 30-session average of 61.3%, on 459K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 309K | 459K | 67.3% | 0 |
| 2026-10-30 | 291K | 605K | 48.1% | 774 |
| 2026-10-29 | 365K | 489K | 74.6% | 1,666 |
| 2026-10-28 | 226K | 383K | 58.9% | 0 |
| 2026-10-27 | 386K | 611K | 63.3% | 0 |
| 2026-10-26 | 224K | 306K | 73.4% | 0 |
| 2026-10-23 | 409K | 649K | 63.1% | 0 |
| 2026-10-22 | 207K | 288K | 71.8% | 0 |
| 2026-10-21 | 521K | 833K | 62.5% | 0 |
| 2026-10-20 | 376K | 593K | 63.4% | 0 |
| 2026-10-19 | 231K | 554K | 41.6% | 0 |
| 2026-10-16 | 318K | 1.0M | 31.8% | 0 |
| 2026-10-15 | 275K | 664K | 41.4% | 0 |
| 2026-10-14 | 506K | 959K | 52.8% | 0 |
| 2026-10-13 | 364K | 506K | 72.0% | 0 |
| 2026-10-12 | 387K | 626K | 61.8% | 0 |
| 2026-10-09 | 507K | 828K | 61.3% | 0 |
| 2026-10-08 | 543K | 1.2M | 44.1% | 0 |
| 2026-10-07 | 694K | 1.0M | 67.8% | 0 |
| 2026-10-06 | 423K | 829K | 51.0% | 0 |
| 2026-10-05 | 271K | 575K | 47.0% | 0 |
| 2026-10-02 | 431K | 726K | 59.3% | 26 |
| 2026-10-01 | 562K | 845K | 66.5% | 0 |
| 2026-09-30 | 733K | 1.0M | 71.2% | 0 |
| 2026-09-29 | 707K | 968K | 73.0% | 0 |
| 2026-09-28 | 536K | 720K | 74.4% | 0 |
| 2026-09-25 | 417K | 583K | 71.5% | 0 |
| 2026-09-24 | 401K | 680K | 59.0% | 0 |
| 2026-09-23 | 375K | 543K | 69.1% | 0 |
| 2026-09-22 | 301K | 389K | 77.4% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 22 September 2026, the fails-to-deliver balance in TRVI is 6,351 shares, up 1 share over the last settlement date. Over the last 30 readings it ranged from 31 shares (23 June 2026) to 347,581 shares (20 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-22 | 6,351 | $14.89 | $95K |
| 2026-09-21 | 6,350 | $14.95 | $95K |
| 2026-09-03 | 1,000 | $17.05 | $17K |
| 2026-08-27 | 1,698 | $17.92 | $30K |
| 2026-08-21 | 129 | $18.25 | $2K |
| 2026-07-24 | 281 | $17.18 | $5K |
| 2026-07-23 | 281 | $17.36 | $5K |
| 2026-07-22 | 1,523 | $18.18 | $28K |
| 2026-07-20 | 347,581 | $19.07 | $6.6M |
| 2026-07-16 | 109 | $18.15 | $2K |
| 2026-07-07 | 129 | $17.95 | $2K |
| 2026-07-06 | 159 | $17.93 | $3K |
| 2026-07-02 | 176 | $17.61 | $3K |
| 2026-07-01 | 64 | $18.65 | $1K |
| 2026-06-30 | 2,000 | $18.63 | $37K |
| 2026-06-29 | 736 | $18.15 | $13K |
| 2026-06-23 | 31 | $17.71 | $549 |
| 2026-06-18 | 1,762 | $16.37 | $29K |
| 2026-06-16 | 196,270 | $14.66 | $2.9M |
| 2026-06-15 | 228 | $14.21 | $3K |
| 2026-06-04 | 2,423 | $13.45 | $33K |
| 2026-06-01 | 460 | $14.14 | $7K |
| 2026-05-20 | 1,758 | $13.24 | $23K |
| 2026-05-19 | 144 | $13.43 | $2K |
| 2026-05-18 | 4,704 | $14.20 | $67K |
| 2026-05-14 | 5,762 | $15.27 | $88K |
| 2026-05-07 | 200 | $14.26 | $3K |
| 2026-04-30 | 7,444 | $13.82 | $103K |
| 2026-04-24 | 421 | $14.19 | $6K |
| 2026-04-23 | 81,694 | $14.80 | $1.2M |
Insider trades
SEC Form 4, newest first. JSONInsiders at TRVI reported 4 open-market sells worth $596K in the last 90 days and no open-market buys. Latest filing: Heffernan Michael Thomas (Director) on 2026-09-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Heffernan Michael Thomas | Director | Sell | 100 | $15.88 | $2K | 6K |
| 2026-09-15 | Heffernan Michael Thomas | Director | Sell | 21K | $15.09 | $316K | 6K |
| 2026-09-15 | Heffernan Michael Thomas | Director | Exercise or conversion | 21K | $3.33 | $70K | 27K |
| 2026-09-15 | Heffernan Michael Thomas | Director | Sell | 100 | $15.88 | $2K | 6K |
| 2026-09-15 | Heffernan Michael Thomas | Director | Sell | 18K | $15.09 | $276K | 6K |
| 2026-09-15 | Heffernan Michael Thomas | Director | Exercise or conversion | 18K | $3.04 | $56K | 25K |
| 2025-12-02 | Galletta Christopher | See Remarks | Exercise or conversion | 4K | $0.51 | $2K | 26K |
| 2025-03-25 | SCIASCIA THOMAS | Chief Scientific Officer | Exercise or conversion | 3K | $1.43 | $4K | 224K |
| 2025-03-25 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 3K | $6.60 | $17K | 221K |
| 2025-03-21 | GOOD JENNIFER L | President & CEO | Sell | 5K | $6.58 | $35K | 213K |
| 2025-03-21 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 5K | $1.43 | $8K | 219K |
| 2025-03-10 | Simon Farrell | Chief Commercial Officer | Sell | 77K | $6.73 | $518K | 81K |
| 2025-03-10 | Simon Farrell | Chief Commercial Officer | Exercise or conversion | 18K | $3.21 | $56K | 63K |
| 2025-03-10 | Simon Farrell | Chief Commercial Officer | Exercise or conversion | 64K | $3.91 | $250K | 127K |
| 2025-03-10 | Simon Farrell | Chief Commercial Officer | Exercise or conversion | 31K | $0.51 | $16K | 158K |
| 2025-03-10 | Simon Farrell | Chief Commercial Officer | Sell | 4K | $7.15 | $31K | 77K |
| 2025-01-08 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 5K | $0.51 | $3K | 65K |
| 2025-01-07 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 1K | $0.51 | $510 | 60K |
| 2024-12-13 | Galletta Christopher | See Remarks | Exercise or conversion | 15K | $0.51 | $8K | 20K |
| 2024-09-09 | GOOD JENNIFER L | President & CEO | Sell | 2K | $3.04 | $6K | 213K |
| 2024-09-09 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 2K | $1.43 | $3K | 215K |
| 2024-09-06 | GOOD JENNIFER L | President & CEO | Sell | 4K | $3.03 | $13K | 213K |
| 2024-09-06 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 4K | $1.43 | $6K | 218K |
| 2024-09-05 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 40K | $1.43 | $58K | 254K |
| 2024-09-05 | GOOD JENNIFER L | President & CEO | Sell | 40K | $3.11 | $125K | 213K |
| 2024-09-04 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 11K | $1.43 | $16K | 224K |
| 2024-09-04 | GOOD JENNIFER L | President & CEO | Sell | 11K | $3.02 | $33K | 213K |
| 2024-09-03 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 4K | $1.43 | $6K | 217K |
| 2024-09-03 | GOOD JENNIFER L | President & CEO | Sell | 4K | $3.02 | $12K | 213K |
| 2024-08-27 | Meeker David P | Director | Sell | 5K | $2.93 | $13K | 352K |
| 2024-08-27 | Meeker David P | Director | Exercise or conversion | 5K | $1.43 | $7K | 357K |
| 2024-08-19 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 16K | $2.96 | $49K | 220K |
| 2024-08-19 | SCIASCIA THOMAS | Chief Scientific Officer | Exercise or conversion | 16K | $1.43 | $24K | 237K |
| 2024-08-16 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 19K | $2.76 | $52K | 220K |
| 2024-08-16 | SCIASCIA THOMAS | Chief Scientific Officer | Exercise or conversion | 19K | $1.43 | $27K | 239K |
| 2024-08-15 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 13K | $2.79 | $36K | 220K |
| 2024-08-15 | SCIASCIA THOMAS | Chief Scientific Officer | Exercise or conversion | 13K | $1.43 | $18K | 233K |
| 2024-08-14 | SCIASCIA THOMAS | Chief Scientific Officer | Exercise or conversion | 100 | $1.43 | $143 | 220K |
| 2024-08-14 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 100 | $2.75 | $275 | 220K |
| 2024-05-29 | SCIASCIA THOMAS | Chief Scientific Officer | Exercise or conversion | 59K | $2.19 | $130K | 268K |
| 2024-05-29 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 53K | $2.55 | $136K | 214K |
| 2024-05-22 | Delfini Lisa | Chief Financial Officer | Sell | 4K | $2.64 | $11K | 53K |
| 2024-05-22 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 16K | $0.51 | $8K | 58K |
| 2024-05-20 | GOOD JENNIFER L | President & CEO | Sell | 25K | $2.86 | $72K | 213K |
| 2024-05-20 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 25K | $2.19 | $55K | 238K |
| 2024-05-10 | GOOD JENNIFER L | President & CEO | Exercise or conversion | 5K | $2.19 | $10K | 218K |
| 2024-05-10 | GOOD JENNIFER L | President & CEO | Sell | 5K | $2.90 | $13K | 213K |
| 2023-10-11 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 37K |
| 2023-10-11 | Delfini Lisa | Chief Financial Officer | Sell | 785 | $2.02 | $2K | 36K |
| 2023-09-11 | Delfini Lisa | Chief Financial Officer | Sell | 711 | $2.20 | $2K | 34K |
| 2023-09-11 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 35K |
| 2023-08-11 | Delfini Lisa | Chief Financial Officer | Sell | 682 | $2.36 | $2K | 33K |
| 2023-08-11 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 33K |
| 2023-07-11 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 32K |
| 2023-07-11 | Delfini Lisa | Chief Financial Officer | Sell | 687 | $2.34 | $2K | 31K |
| 2023-06-20 | Simon Farrell | Chief Commercial Officer | Exercise or conversion | 6K | $0.51 | $3K | 46K |
| 2023-06-12 | Delfini Lisa | Chief Financial Officer | Sell | 610 | $2.64 | $2K | 30K |
| 2023-06-12 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 30K |
| 2023-05-11 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 28K |
| 2023-05-11 | Delfini Lisa | Chief Financial Officer | Sell | 562 | $2.89 | $2K | 28K |
| 2023-04-11 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 27K |
| 2023-04-11 | Delfini Lisa | Chief Financial Officer | Sell | 840 | $1.84 | $2K | 26K |
| 2023-03-13 | Delfini Lisa | Chief Financial Officer | Sell | 892 | $1.75 | $2K | 25K |
| 2023-03-13 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 2K | $0.51 | $1K | 26K |
| 2023-03-07 | Simon Farrell | Chief Commercial Officer | Exercise or conversion | 19K | $0.51 | $10K | 39K |
| 2023-02-13 | Delfini Lisa | Chief Financial Officer | Sell | 8K | $2.45 | $21K | 23K |
| 2023-02-13 | Delfini Lisa | Chief Financial Officer | Exercise or conversion | 28K | $0.51 | $14K | 32K |
| 2022-07-05 | WINKELRIED JON | Other | Sell | 64K | $3.11 | $198K | 3.8M |
| 2022-07-01 | WINKELRIED JON | Other | Sell | 436K | $2.86 | $1.2M | 3.9M |
| 2022-06-30 | WINKELRIED JON | TenPercentOwner | Sell | 430K | $2.77 | $1.2M | 4.3M |
| 2022-06-29 | WINKELRIED JON | TenPercentOwner | Sell | 46K | $2.74 | $126K | 4.8M |
| 2022-05-02 | COULTER JAMES G | TenPercentOwner | Sell | 600 | $2.70 | $2K | 4.8M |
| 2022-04-29 | COULTER JAMES G | TenPercentOwner | Sell | 16K | $2.75 | $44K | 4.8M |
| 2022-04-28 | COULTER JAMES G | TenPercentOwner | Sell | 7K | $2.77 | $20K | 4.8M |
| 2022-04-11 | NEA 16 GP, LLC | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | BASKETT FOREST | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | Behbahani Ali | TenPercentOwner | Buy | 949K | $1.90 | $1.8M | 949K |
| 2022-04-11 | Behbahani Ali | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | Chang Carmen | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | Chang Carmen | TenPercentOwner | Buy | 949K | $1.90 | $1.8M | 949K |
| 2022-04-11 | Florence Anthony A. Jr. | TenPercentOwner | Buy | 949K | $1.90 | $1.8M | 949K |
| 2022-04-11 | Florence Anthony A. Jr. | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | Makhzoumi Mohamad | TenPercentOwner | Buy | 949K | $1.90 | $1.8M | 949K |
| 2022-04-11 | Makhzoumi Mohamad | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | SANDELL SCOTT D | TenPercentOwner | Buy | 949K | $1.90 | $1.8M | 949K |
| 2022-04-11 | SANDELL SCOTT D | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | Sonsini Peter W. | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | Sonsini Peter W. | TenPercentOwner | Buy | 949K | $1.90 | $1.8M | 949K |
| 2022-04-11 | Walker Paul Edward | TenPercentOwner | Buy | 2.6M | $1.90 | $5.0M | 10.4M |
| 2022-04-11 | Walker Paul Edward | TenPercentOwner | Buy | 949K | $1.90 | $1.8M | 949K |
| 2022-04-11 | Mathers Edward T | Director | Grant | 949K | $1.90 | $1.8M | 949K |
| 2021-10-18 | NEA Partners 16, L.P. | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | BASKETT FOREST | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | Behbahani Ali | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | Chang Carmen | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | Florence Anthony A. Jr. | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | Makhzoumi Mohamad | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | SANDELL SCOTT D | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | Sonsini Peter W. | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
| 2021-10-18 | Walker Paul Edward | TenPercentOwner | Buy | 1.9M | $1.62 | $3.0M | 7.8M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON3 Form 144 notices on file for TRVI worth $2.0M at the prices reported; 1 in the last 90 days worth $627K. Latest: MICHAEL HEFFERNAN filed on 2026-09-15 to sell 39,473 shares ($627K) from 2026-09-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-15 | MICHAEL HEFFERNANDirector | 39K | $627K | 0.028% | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-07 | Delfini LisaOfficer | 109K | $1.0M | 0.089% | 2025-10-07 | Stifel Nicolaus & Company Inc |
| 2025-10-03 | Delfini LisaOfficer | 40K | $387K | 0.033% | 2025-10-03 | Stifel Nicolaus & Company Inc |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON19 holders report 5% or more of TRVI in their latest filing, 13 on Schedule 13D (active intent). The largest reported stake is NEA 16 GP, LLC at 10.5% of the class (15,074,080 shares), filed 2026-05-07 for an event on 2026-05-05.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-27 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 9.8M | 6.9% | 2026-09-30 |
| 2026-08-06 | 13G/Ano. 2 | FMR LLCparent holding company | 12.6M | 8.8% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | Abigail P. Johnsonindividual | 12.6M | 8.8% | 2026-06-30 |
| 2026-05-07 | 13D/Ano. 9 | NEA 16 GP, LLCother entity | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | NEA 18 Venture Growth Equity, L.P.partnership | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | NEA Partners 18 VGE, L.P.partnership | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | NEA 18 VGE GP, LLCother entity | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | Ali Behbahaniindividual | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | Carmen Changindividual | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | Anthony A. Florence, Jr.individual | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | Mohamad H. Makhzoumiindividual | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | Scott D. Sandellindividual | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | Paul Walkerindividual | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | New Enterprise Associates 16, L.P.partnership | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | NEA Partners 16, L.P.partnership | 15.1M | 10.5% | 2026-05-05 |
| 2026-05-07 | 13D/Ano. 9 | Forest Baskettindividual | 14.1M | 9.8% | 2026-05-05 |
| 2026-03-27 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-13 | 13G/Ano. 1 | David Rosenparent holding company, individual | 3.8M | 2.9% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Rubric Capital Management LPinvestment adviser, partnership | 3.8M | 2.9% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 5 | Frazier Life Sciences Public Fund, L.P.partnership | 8.5M | 7.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | FHMLSP, L.P.partnership | 8.5M | 7.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | FHMLSP, L.L.C.other entity | 8.5M | 7.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | FHMLS XI, L.L.C.other entity | 1.4M | 1.1% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | FHMLS XI, L.P.partnership | 1.4M | 1.1% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Frazier Life Sciences XI, L.P.partnership | 1.4M | 1.1% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | FHMLS X, L.L.C.other entity | 397K | 0.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | FHMLS X, L.P.partnership | 397K | 0.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Frazier Life Sciences X, L.P.partnership | 397K | 0.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Patrick J. Heronindividual | 397K | 0.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | James N. Topperindividual | 397K | 0.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Albert Chaindividual | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | James Brushindividual | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Daniel Estesindividual | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Shabet Rose Sharonindividual | 5.1M | 4.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | HALVORSEN OLE ANDREASindividual | 5.1M | 4.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Viking Global Opportunities Parent GP LLCother entity | 5.1M | 4.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | VIKING GLOBAL INVESTORS LPpartnership | 5.1M | 4.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Ott David C.individual | 5.1M | 4.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Viking Global Opportunities Portfolio GP LLCother entity | 3.4M | 2.8% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Viking Global Opportunities GP LLCother entity | 3.4M | 2.8% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Viking Global Opportunities Illiquid Investments Sub-Master LPpartnership | 3.4M | 2.8% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Viking Global Opportunities Drawdown (Aggregator) LPpartnership | 1.7M | 1.4% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Viking Global Opportunities Drawdown GP LLCother entity | 1.7M | 1.4% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Viking Global Opportunities Drawdown Portfolio GP LLCother entity | 1.7M | 1.4% | 2025-09-30 |
13F holders
Tracked managers holding TRVI at their latest 13F. JSON2 of the 30 tracked managers held TRVI at their latest 13F, $34.1M in total at quarter-end prices. Viking Global Investors is the largest at $28.8M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Viking Global Investors | 2026-06-30 | 1.5M | $28.8M | 0.08% | -1.7M |
| D. E. Shaw & Co. | 2026-06-30 | 282K | $5.3M | 0.00% | +101K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Trevi Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Trevi Therapeutics (TRVI), SEC CIK 1563880, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-22.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-27.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 1563880Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of TRVI is sold short?
16,007,187 shares were held short at the 2026-10-15 settlement, 4.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is TRVI's daily short volume?
On 2026-11-02, 308,712 of the 458,699 TRVI shares reported to FINRA were sold short, 67.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does TRVI have fails to deliver?
The SEC's latest file shows 6,351 TRVI shares failed to deliver at settlement 2026-09-22. Fails are reported per settlement date and published twice a month with a lag.
Are TRVI insiders buying or selling?
Insiders at TRVI reported 4 open-market sells worth $596K in the last 90 days and no open-market buys. Latest filing: Heffernan Michael Thomas (Director) on 2026-09-15.
Have TRVI insiders filed to sell?
3 Form 144 notices on file for TRVI worth $2.0M at the prices reported; 1 in the last 90 days worth $627K. Latest: MICHAEL HEFFERNAN filed on 2026-09-15 to sell 39,473 shares ($627K) from 2026-09-15.
Who owns 5% or more of TRVI?
19 holders report 5% or more of TRVI in their latest filing, 13 on Schedule 13D (active intent). The largest reported stake is NEA 16 GP, LLC at 10.5% of the class (15,074,080 shares), filed 2026-05-07 for an event on 2026-05-05.
Which tracked 13F managers own TRVI?
2 of the 30 tracked 13F managers held TRVI shares at their latest filing, $34.1M in all. The largest: Andreas Halvorsen's Viking Global Investors (1.5M shares, $28.8M), D. E. Shaw & Co. (282K shares, $5.3M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.